VSee Health, Inc. Pre-Tax Income
VSee Health, Inc. (VSEE) reported Pre-Tax Income of -$3.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-14
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$3.10M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$2.58M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$7.80M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$289.75K.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$14.64M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$59.34M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$1.89M.
- VSee Health, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$3.06M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.10M 10-Q · filed 2026-08-14 | -$4.34M 10-Q · filed 2026-08-14 | -$13.47M derived: sum of 3 quarters · filed 2026-08-14 | -$13.76M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | -$2.58M 10-Q · filed 2026-05-15 | -$10.38M derived: sum of 2 quarters · filed 2026-05-15 | -$10.67M derived: sum of 3 quarters · filed 2026-05-15 | -$12.57M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.09M derived: sum of 2 quarters · filed 2026-03-31 | -$9.99M derived: sum of 3 quarters · filed 2026-08-14 | -$14.64M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | -$289.75K 10-Q · filed 2025-11-14 | -$2.19M derived: sum of 2 quarters · filed 2026-08-14 | -$6.84M 10-Q · filed 2025-11-14 | -$9.32M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | -$1.90M 10-Q · filed 2026-08-14 | -$2.61M 10-Q · filed 2025-10-15 | -$5.53M 10-Q · filed 2026-08-14 | -$6.55M 10-Q · filed 2025-10-15 | -$9.03M derived: sum of 3 quarters · filed 2026-08-14 | -$62.94M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$3.95M 10-Q · filed 2026-05-15 | -$7.13M derived: sum of 2 quarters · filed 2026-05-15 | -$61.04M derived: sum of 3 quarters · filed 2026-05-15 | -$63.39M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$57.10M derived: sum of 2 quarters · filed 2026-03-31 | -$59.44M derived: sum of 3 quarters · filed 2026-03-31 | -$59.34M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$53.91M 10-Q · filed 2025-11-14 | -$52.30M 10-Q · filed 2024-11-14 | -$56.26M derived: sum of 2 quarters · filed 2025-11-20 | -$56.16M 10-Q · filed 2025-11-14 | -$54.88M 10-Q · filed 2024-11-14 | -$56.24M derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-06-30 | -$2.34M 10-Q/A · filed 2025-11-20 | -$2.60M 10-Q · filed 2024-09-23 | -$2.25M 10-Q/A · filed 2025-11-20 | -$2.57M 10-Q · filed 2024-09-23 | -$2.33M derived: sum of 3 quarters · filed 2025-11-20 | -$2.74M derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-03-31 | $94.75K 10-Q · filed 2025-10-15 | -$967.82K 10-Q · filed 2024-05-15 | $18.05K derived: sum of 2 quarters · filed 2025-10-15 | -$392.96K derived: sum of 3 quarters · filed 2025-10-15 | -$1.07M derived: sum of 4 quarters · filed 2025-10-15 | ||||
| 2023-12-31 | -$76.70K derived: 10-K/A 12 month − 10-K/A 9 month · filed 2025-08-29 | -$487.71K derived: sum of 2 quarters · filed 2025-08-29 | -$1.17M derived: sum of 3 quarters · filed 2025-08-29 | -$1.89M 10-K/A · filed 2025-08-29 | -$4.41M 10-K · filed 2024-04-12 | ||||
| 2023-09-30 | -$411.01K 10-K/A · filed 2025-08-29 | $78.29K 10-Q · filed 2023-11-20 | -$1.09M derived: sum of 2 quarters · filed 2025-08-29 | -$1.81M 10-K/A · filed 2025-08-29 | -$1.55M 10-Q · filed 2023-11-20 | -$2.94M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2023-06-30 | -$681.69K 10-K/A · filed 2025-08-29 | $263.55K 10-Q · filed 2023-08-21 | -$1.40M 10-K/A · filed 2025-08-29 | -$1.63M 10-Q · filed 2023-08-21 | -$2.53M derived: sum of 3 quarters · filed 2025-08-29 | -$3.27M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2023-03-31 | -$717.57K 10-K/A · filed 2025-08-29 | -$1.89M 10-Q · filed 2023-05-15 | -$1.85M derived: sum of 2 quarters · filed 2025-08-29 | -$2.59M derived: sum of 3 quarters · filed 2025-08-29 | -$3.25M derived: sum of 4 quarters · filed 2025-08-29 | ||||
| 2022-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | -$1.87M derived: sum of 2 quarters · filed 2024-04-12 | -$2.53M derived: sum of 3 quarters · filed 2024-04-12 | -$3.06M 10-K · filed 2024-04-12 | |||||
| 2022-09-30 | -$737.73K 10-Q · filed 2023-11-20 | -$1.40M derived: sum of 2 quarters · filed 2023-11-20 | -$1.92M 10-Q · filed 2023-11-20 | ||||||
| 2022-06-30 | -$659.46K 10-Q · filed 2023-08-21 | -$1.19M 10-Q · filed 2023-08-21 | |||||||
| 2022-03-31 | -$527.36K 10-Q · filed 2023-05-15 | ||||||||
| 2021-12-31 | -$280.70K 10-K · filed 2023-04-12 | ||||||||
| 2021-09-30 | -$180.00 10-Q · filed 2022-11-10 | -$5.18K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |